🏅 FDA Orphan Designation
Skyclarys
omaveloxolone
Manufacturer: Biogen U.S. Corporation
Indicated for:
Friedreich ataxiaOrphan
FDA-Approved Indications (1)
Friedreich ataxiaOrphan Designation
treatment of Friedreich's ataxia in adults and adolescents aged 16 years and older
Indications & Usage
1 INDICATIONS AND USAGE SKYCLARYS is indicated for the treatment of Friedreich's ataxia in adults and adolescents aged 16 years and older. SKYCLARYS is indicated for the treatment of Friedreich's ataxia in adults and adolescents aged 16 years and older. ( 1 )
💙 Support Programs
View all →Skyclarys
Biogen U.S. Corporation
Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.
Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.